Covidien plc to Report First-Quarter Results on January 25, 2013
DUBLIN -- December 12, 2012
Covidien plc (NYSE: COV) will report first-quarter results on January 25,
2013, before trading begins. The Company will hold a conference call for
investors at 8:30 a.m. ET. The call can be accessed in the following ways:
*At Covidien’s website: http://investor.covidien.com
*By telephone: For both “listen-only” participants and those participants
who wish to take part in the question-and-answer portion of the call, the
telephone dial-in number in the U.S. is 800-561-2693. For participants
outside the U.S., the dial-in number is 617-614-3523. The access code for
all callers is 83035324.
*Through an audio replay: A replay of the conference call will be available
beginning at 11:30 a.m. on January 25, 2013, and ending at 5:00 p.m. on
February 1, 2013. The dial-in number for U.S. participants is
888-286-8010. For participants outside the U.S., the replay dial-in number
is 617-801-6888. The replay access code for all callers is 90266221.
Covidien is a leading global healthcare products company that creates
innovative medical solutions for better patient outcomes and delivers value
through clinical leadership and excellence. Covidien manufactures, distributes
and services a diverse range of industry-leading product lines in three
segments: Medical Devices, Pharmaceuticals and Medical Supplies. With 2012
revenue of $11.9 billion, Covidien has 43,000 employees worldwide in 70
countries, and its products are sold in over 140 countries. Please visit
www.covidien.com to learn more about our business.
Eric Kraus, 508-261-8305
Senior Vice President
Coleman Lannum, CFA, 508-452-4343
Bruce Farmer, 508-452-4372
Todd Carpenter, 508-452-4363
Press spacebar to pause and continue. Press esc to stop.